Docetaxel

Ország: Új-Zéland

Nyelv: angol

Forrás: Medsafe (Medicines Safety Authority)

Aktív összetevők:

Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg

Beszerezhető a:

REX Medical Ltd

INN (nemzetközi neve):

Docetaxel trihydrate 25.177 mg (equivalent to anhydrous docetaxel 20mg)

Adagolás:

20 mg/mL

Gyógyszerészeti forma:

Concentrate for infusion

Összetétel:

Active: Docetaxel trihydrate 25.177mg equivalent to anhydrous docetaxel 20mg Excipient: Citric acid Polysorbate 80 Ethanol Water for injection

db csomag:

Vial, glass, Diluent, 1.5 mL

Osztály:

Prescription

Recept típusa:

Prescription

Gyártó:

Cipla Ltd

Terápiás javallatok:

Docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. Docetaxel in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy. Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours express HER2 and who previously have not received chemotherapy for metastatic disease.

Termék összefoglaló:

Package - Contents - Shelf Life: Vial, glass, Diluent - 1.5 mL - 24 months from date of manufacture - Vial, glass, concentrate solution - 20 mg - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze)

Engedély dátuma:

2006-06-23